scout
Quiz|Articles|July 21, 2024

Targeted Pulse Quiz: July 21

Author(s)Morgan Bayer

Test your knowledge on the current pulse of oncology including FDA updates and breaking data with our Targeted Pulse Quiz.

Ready for the challenge? Let’s begin!

Which combination therapy showed superior progression-free survival compared with osimertinib for EGFR-mutated NSCLC?


Learn More: The Targeted Pulse Week of July 21

Newsletter

Stay up to date on practice-changing data in community practice.

Latest CME